Supraspinatus Tendonitis
Conditions
Keywords
TECAR, supraspinatus tendonitis, sub acromial space
Brief summary
Is the TECAR therapy effective on supraspinatus tendon thickness, sub acromial space, pain intensity , shoulder range of motion, muscle strength ( supraspinatus and middle fiber of deltoid) and functional disabilities in patients with supraspinatus tendinitis?
Detailed description
Supraspinatus tendinitis is a common disorder of the rotator cuff characterized by inflammation and degeneration of the supraspinatus tendon, typically resulting from repetitive overhead activities, mechanical impingement beneath the acromion, or age-related degenerative changes. This condition often leads to shoulder pain, reduced range of motion, and functional impairment during arm elevation and overhead movements. Recently, Studies demonstrated that the addition of TECAR therapy to a standard physiotherapy regimen improves shoulder pain, disability, and passive range of motion in patients with adhesive capsulitis, supporting the use of TECAR as an effective modality in shoulder musculoskeletal rehabilitation.
Interventions
OTHERTECAR therapy
Patients will be in a comfortable side-lying with treated shoulder uppermost and clean the area over the affected shoulder, apply coupling medium and then apply Capacitive mode to shoulder muscles for 10 minutes and Resistive mode for another 10 minutes.
OTHERconventional physiotherapy
Patients will receive conventional physiotherapy (range of motion exercises, stretching exercises, strengthening exercises, and scapular stabilization exercises).
Sponsors
Cairo University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
1. Fifty patients with chronic supraspinatus tendinitis on the dominant side. 2. Patients with age range from 18 to 65 years old from both genders. 3. Patients reporting positive empty can test. 4. patients reporting pain with resisted isometric abduction. 5. Patients experiencing shoulder pain for at least 4 weeks. 6. patients reporting pain with active shoulder elevation in the scapular plane.
Exclusion criteria
1. Patients with shoulder surgery or trauma in the past 6 months will be excluded. 2. Patients with full-thickness rotator cuff tears, fractures, or severe osteoarthritis will be excluded. 3. Patients with systemic diseases affecting tendon healing (e.g., uncontrolled diabetes, rheumatoid arthritis) will be excluded. 4. Patients who were pregnant or breastfeeding will be excluded. 5. Patients currently receiving other shoulder therapies that could affect outcomes will be excluded. 6. Patients with frozen shoulder will be excluded. 7. Patients with glenohumeral or acromioclavicular arthritis will be excluded. 8. Patients with an implanted pacemaker will be excluded.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| tendon thickness of supraspinatus muscle | up to four weeks | tendon thickness of supraspinatus muscle will be measured by ultrasonography |
| Sub acromial space | up to four weeks | Sub acromial space will be assessed using Ultrasonography. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| pain intensity | up to four weeks | visual analogue scale (VAS) will be used to asses pain intensity which patient will be instructed to put point on line from no pain to tolerable pain. The scale consists of a line, usually 10 cm long, ranging from no pain or discomfort (zero) , to the worst pain that could possibly feel (10). |
| Shoulder Range of motion | up to four weeks | Shoulder range of motion will be assessed using an electro goniometer. |
| Muscle strength | up to four weeks | Muscle strength will be assessed using a handheld dynamometer (Lafayette Manual Muscle Tester). |
| Shoulder functional disability | up to four weeks | Shoulder functional disability will be assessed using the Disabilities of the Arm, Shoulder and Hand (DASH). Quick DASH questionnaire is an 11-item patient-reported outcome measure designed to evaluate physical function and symptoms in individuals with upper extremity disorders. Each item is scored on a 5-point Likert scale ranging from "no difficulty" to "unable," and the total score is calculated by transforming the mean of the responses into a 0-100 scale, where higher scores indicate greater disability. |
Countries
Egypt
Contacts
CONTACTShireen M Mahmoud, Demonstrator
STUDY_DIRECTORAlshaymaa Sh Abd El-Azeim, PHD
Assistant professor
Outcome results
None listed